71 related articles for article (PubMed ID: 7909417)
41. Clonal growth in the Hamburger-Salmon assay improved by rat RBCs.
Katoh A; Charoensiri S; Fogarty P; Patterson R
Anticancer Res; 1985; 5(2):231-4. PubMed ID: 3994313
[TBL] [Abstract][Full Text] [Related]
42. Cytotoxic effect of xanthotoxol (8-hydroxypsoralen) on TCTC cells in vitro.
Gawron A; Kruk I
Pol J Pharmacol Pharm; 1992; 44(1):51-7. PubMed ID: 1437852
[TBL] [Abstract][Full Text] [Related]
43. Control of nuclear division in normal but not in neoplastic mouse cells.
O'Neill FJ
Cancer Res; 1974 May; 34(5):1070-3. PubMed ID: 4858384
[No Abstract] [Full Text] [Related]
44. A novel flow cytometric technique for drug cytotoxicity gives results comparable to colony-forming assays.
Poot M; Silber JR; Rabinovitch PS
Cytometry; 2002 May; 48(1):1-5. PubMed ID: 12116374
[TBL] [Abstract][Full Text] [Related]
45. Growth of cells superinoculated onto irradiated and nonirradiated confluent monolayers.
Matsuoka H; Ueo H; Sugimachi K
Semin Surg Oncol; 1990; 6(1):48-52. PubMed ID: 2300732
[TBL] [Abstract][Full Text] [Related]
46. Inhibition by lymphoblastoid interferon of growth of cells derived from the human breast.
Balkwill F; Watling D; Taylor-Papadimitriou J
Int J Cancer; 1978 Sep; 22(3):258-65. PubMed ID: 700890
[TBL] [Abstract][Full Text] [Related]
47. [Detection of the anti-cancer biological effect of naphthoquinone pigment-LIII].
Lu G; Liao J
Zhong Xi Yi Jie He Za Zhi; 1990 Jul; 10(7):422-5, 390. PubMed ID: 2208424
[TBL] [Abstract][Full Text] [Related]
48. In vitro cytotoxicity assays. Potential alternatives to the Draize ocular allergy test.
Borenfreund E; Borrero O
Cell Biol Toxicol; 1984 Oct; 1(1):55-65. PubMed ID: 6400923
[TBL] [Abstract][Full Text] [Related]
49. In vitro cytotoxicity evaluation of plastic biomedical devices.
Pant AB; Agarwal AK; Sharma VP; Seth PK
Hum Exp Toxicol; 2001 Aug; 20(8):412-7. PubMed ID: 11727792
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the sensitivity of three toxicity tests determining survival, inhibition of growth and colony-forming ability in human fibroblasts after incubation with environmental chemicals.
Witte I; Frahmann E; Jacobi H
Toxicol In Vitro; 1995 Jun; 9(3):327-31. PubMed ID: 20650094
[TBL] [Abstract][Full Text] [Related]
51. A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy.
Liu Y; Hong G; Mao L; Su Z; Liu T; Liu H
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175072
[TBL] [Abstract][Full Text] [Related]
52. Advantages of Using Paclitaxel in Combination with Oncolytic Adenovirus Utilizing RNA Destabilization Mechanism.
Hossain E; Habiba U; Yanagawa-Matsuda A; Alam A; Ahmed I; Alam MT; Yasuda M; Higashino F
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32408515
[TBL] [Abstract][Full Text] [Related]
53. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.
Babu A; Amreddy N; Muralidharan R; Pathuri G; Gali H; Chen A; Zhao YD; Munshi A; Ramesh R
Sci Rep; 2017 Nov; 7(1):14674. PubMed ID: 29116098
[TBL] [Abstract][Full Text] [Related]
54. Effect of
Hertz E; Cadoná FC; Machado AK; Azzolin V; Holmrich S; Assmann C; Ledur P; Ribeiro EE; DE Souza Filho OC; Mânica-Cattani MF; DA Cruz IB
Mol Clin Oncol; 2015 Jan; 3(1):37-43. PubMed ID: 25469267
[TBL] [Abstract][Full Text] [Related]
55. Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety.
Zhu L; Wang T; Perche F; Taigind A; Torchilin VP
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17047-52. PubMed ID: 24062440
[TBL] [Abstract][Full Text] [Related]
56. Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.
Tsukada T; Fushida S; Harada S; Terai S; Yagi Y; Kinoshita J; Oyama K; Tajima H; Ninomiya I; Fujimura T; Ohta T
Int J Oncol; 2013 Apr; 42(4):1167-74. PubMed ID: 23443842
[TBL] [Abstract][Full Text] [Related]
57. Paclitaxel interrupts TGF-beta1 signaling between gallbladder epithelial cells and myofibroblasts.
Choi HS; Savard CE; Choi JW; Kuver R; Lee SP
J Surg Res; 2007 Aug; 141(2):183-91. PubMed ID: 17574589
[TBL] [Abstract][Full Text] [Related]
58. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.
Spencer CM; Faulds D
Drugs; 1994 Nov; 48(5):794-847. PubMed ID: 7530632
[TBL] [Abstract][Full Text] [Related]
59. Difference in cytotoxicity of paclitaxel against neoplastic and normal cells.
Matsuoka H; Furusawa M; Tomoda H; Seo Y
Anticancer Res; 1994; 14(1A):163-7. PubMed ID: 7909417
[TBL] [Abstract][Full Text] [Related]
60. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK
Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
